911789-75-8Relevant academic research and scientific papers
COMPOUNDS FOR THE TREATMENT OF ALZHEIMER'S DISEASE
-
Page/Page column 83, (2010/06/19)
The invention relates to substituted 1,2-ethylenediamines of general formula (I), wherein the radicals R1-R13, A, B, L and i are as defined in the description and the claims. The invention also relates to the use thereof for treating Alzheimer's disease (AD) and similar diseases.
COMPOUNDS FOR THE TREATMENT OF ALZHEIMER'S DISEASE
-
Page/Page column 69, (2010/07/08)
The invention relates to substituted 1,2-ethylenediamines of general formula (I), wherein the radicals R1-R13, A, B, L and i are as defined in the description and in the claims. The invention also relates to the use thereof for treat
INHIBITORS OF BETA-SECRETASE FOR THE TREATMENT OF ALZHEIMER'S DISEASE
-
Page/Page column 34, (2010/12/29)
The invention relates to the substituted 1,2-ethylenediamines of general formula (I), wherein the groups R1 to R13, A, B, L and i are defined as in the description and the claims. The invention also relates to the use thereof in the
COMPOUNDS FOR THE TREATMENT OF ALZHEIMER'S DISEASE
-
Page/Page column 40-41, (2009/03/07)
The invention relates to substituted 1,2-ethylenediamines of general formula (I), wherein the radicals R1 to R13, A, B, L, and i are defined as indicated in the description and the claims, as well as the use thereof for treating Alzheimer''s disease (AD)
Substituted 1,2-ethylenediamines, Methods for Preparing Them and Uses Thereof
-
Page/Page column 208, (2010/11/24)
The present invention relates to substituted 1,2-ethylenediamines of general formula (I) wherein the groups R1 to R15, A, B, L, i as well as X1-X4 are defined as in the specification and claims and the use thereof for the treatment of Alzheimer's disease (AD) and similar diseases.
